Alcon Inc.(0A0D) News

Date	Title
Apr 7	Alcon Publishes Agenda for 2024 Annual General Meeting
Jan 9	Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye